gabexate has been researched along with lysophosphatidylcholines in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Filler, RD; Kahle, M; König, H | 1 |
| Alles, JU; Kahle, M; Klein, U; König, W; Martin, U | 1 |
2 other study(ies) available for gabexate and lysophosphatidylcholines
| Article | Year |
|---|---|
Lysolecithin concentration in pancreatic tissue during therapy with phospholipase A2-inhibitors in acute necrotizing pancreatitis.
Topics: Acute Disease; Animals; Chlorpromazine; Dogs; Dose-Response Relationship, Drug; Edetic Acid; Female; Gabexate; Guanidines; Lysophosphatidylcholines; Male; Necrosis; Pancreas; Pancreatitis; Phospholipases; Phospholipases A; Phospholipases A2 | 1989 |
[Phospholipase A2 inhibitors in hemorrhagic-necrotizing pancreatitis. Animal experiment evaluation of a new treatment concept].
Topics: Acute Disease; Animals; Chlorpromazine; Dogs; Edetic Acid; Female; Gabexate; Guanidines; Hemodynamics; Hemorrhage; Lysophosphatidylcholines; Male; Necrosis; Pancreatitis; Phospholipases; Phospholipases A; Phospholipases A2 | 1985 |